CD3E and head and neck squamous cell carcinoma: To explore changes in immune cell content within murine HNSCC tumors, B4B8 tumors treated for 3, 7 and 14 days with AZD8931 were stained for CD3e and either CD4 or CD8α by immunofluorescence.